ORTX - Orchard Therapeutics: Cutting-Edge Science Beset With A Pioneer's Typical Hurdles
- ORTX is a developer of autologous gene therapies for rare diseases.
- Recent regulatory updates have taken the stock down.
- While there's a lot of promise in science, we will stay on the sidelines.
For further details see:
Orchard Therapeutics: Cutting-Edge Science Beset With A Pioneer's Typical Hurdles